Ultragenyx Analyst Day Presentation

We are leading the future of rare disease medicine Most productive rare disease company in the industry Near-term catalysts for key clinical programs QQQ 窗窗窗 Expect multiple blockbuster product approvals in 2-3 years $ Revenue growth and expense management support path to profitability 18 Confidential and Proprietary ultragenyx

View entire presentation